Identification of an AP2-family Protein That is Critical for Malaria Liver Stage Development

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2012 Nov 13

PMID 23144823

Citations 68

Authors

Shiroh Iwanaga

Izumi Kaneko

Tomomi Kato

Masao Yuda

Affiliations

Soon will be listed here.

Abstract

Liver-stage malaria parasites are a promising target for drugs and vaccines against malaria infection. However, little is currently known about gene regulation in this stage. In this study, we used the rodent malaria parasite Plasmodium berghei and showed that an AP2-family transcription factor, designated AP2-L, plays a critical role in the liver-stage development of the parasite. AP2-L-depleted parasites proliferated normally in blood and in mosquitoes. However, the ability of these parasites to infect the liver was approximately 10,000 times lower than that of wild-type parasites. In vitro assays showed that the sporozoites of these parasites invaded hepatocytes normally but that their development stopped in the middle of the liver schizont stage. Expression profiling using transgenic P. berghei showed that fluorescent protein-tagged AP2-L increased rapidly during the liver schizont stage but suddenly disappeared with the formation of the mature liver schizont. DNA microarray analysis showed that the expression of several genes, including those of parasitophorous vacuole membrane proteins, was significantly decreased in the early liver stage of AP2-L-depleted parasites. Investigation of the targets of this transcription factor should greatly promote the exploration of liver-stage antigens and the elucidation of the mechanisms of hepatocyte infection by malaria parasites.

Citing Articles

Genome-wide gene expression profiles throughout human malaria parasite liver stage development in humanized mice.

Zanghi G, Patel H, Smith J, Camargo N, Bae Y, Hesping E Nat Microbiol. 2025; 10(2):569-584.

PMID: 39891010 PMC: 11790487. DOI: 10.1038/s41564-024-01905-5.

MORC protein regulates chromatin accessibility and transcriptional repression in the human malaria parasite, .

Chahine Z, Gupta M, Lenz T, Hollin T, Abel S, Banks C Elife. 2024; 12.

PMID: 39636094 PMC: 11620747. DOI: 10.7554/eLife.92499.

Transcriptomic Insights into the Developmental Dynamics of : A Comparative Study of a Precocious Line and the Wild Type.

Zhang N, Li X, Liu J, Chen L, Zhang S, Liu X Genes (Basel). 2024; 15(7).

PMID: 39062610 PMC: 11276583. DOI: 10.3390/genes15070831.

The RNA-binding KH-domain in the unique transcription factor of the malaria parasite is responsible for its transcriptional regulatory activity.

Komaki-Yasuda K, Kano S PLoS One. 2023; 18(12):e0296165.

PMID: 38128025 PMC: 10734933. DOI: 10.1371/journal.pone.0296165.

DNA-binding protein PfAP2-P regulates parasite pathogenesis during malaria parasite blood stages.

Subudhi A, Green J, Satyam R, Salunke R, Lenz T, Shuaib M Nat Microbiol. 2023; 8(11):2154-2169.

PMID: 37884813 PMC: 10627835. DOI: 10.1038/s41564-023-01497-6.

References

Painter H, Campbell T, Llinas M . The Apicomplexan AP2 family: integral factors regulating Plasmodium development. Mol Biochem Parasitol. 2010; 176(1):1-7. PMC: 3026892. DOI: 10.1016/j.molbiopara.2010.11.014. View

Aly A, Lindner S, MacKellar D, Peng X, Kappe S . SAP1 is a critical post-transcriptional regulator of infectivity in malaria parasite sporozoite stages. Mol Microbiol. 2011; 79(4):929-39. DOI: 10.1111/j.1365-2958.2010.07497.x. View

Campbell T, De Silva E, Olszewski K, Elemento O, Llinas M . Identification and genome-wide prediction of DNA binding specificities for the ApiAP2 family of regulators from the malaria parasite. PLoS Pathog. 2010; 6(10):e1001165. PMC: 2965767. DOI: 10.1371/journal.ppat.1001165. View

Ishino T, Yano K, Chinzei Y, Yuda M . Cell-passage activity is required for the malarial parasite to cross the liver sinusoidal cell layer. PLoS Biol. 2004; 2(1):E4. PMC: 314464. DOI: 10.1371/journal.pbio.0020004. View

Yuda M, Iwanaga S, Shigenobu S, Mair G, Janse C, Waters A . Identification of a transcription factor in the mosquito-invasive stage of malaria parasites. Mol Microbiol. 2009; 71(6):1402-14. DOI: 10.1111/j.1365-2958.2009.06609.x. View

Aly A, Mikolajczak S, Rivera H, Camargo N, Jacobs-Lorena V, Labaied M . Targeted deletion of SAP1 abolishes the expression of infectivity factors necessary for successful malaria parasite liver infection. Mol Microbiol. 2008; 69(1):152-63. PMC: 2615191. DOI: 10.1111/j.1365-2958.2008.06271.x. View

Tarun A, Dumpit R, Camargo N, Labaied M, Liu P, Takagi A . Protracted sterile protection with Plasmodium yoelii pre-erythrocytic genetically attenuated parasite malaria vaccines is independent of significant liver-stage persistence and is mediated by CD8+ T cells. J Infect Dis. 2007; 196(4):608-16. DOI: 10.1086/519742. View

Hoffman S, Goh L, Luke T, Schneider I, Le T, Doolan D . Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. J Infect Dis. 2002; 185(8):1155-64. DOI: 10.1086/339409. View

Ishino T, Chinzei Y, Yuda M . Two proteins with 6-cys motifs are required for malarial parasites to commit to infection of the hepatocyte. Mol Microbiol. 2005; 58(5):1264-75. DOI: 10.1111/j.1365-2958.2005.04801.x. View

10.

White K, Snyder H, Krzych U . MHC class I-dependent presentation of exoerythrocytic antigens to CD8+ T lymphocytes is required for protective immunity against Plasmodium berghei. J Immunol. 1996; 156(9):3374-81. View

11.

Mueller A, Camargo N, Kaiser K, Andorfer C, Frevert U, Matuschewski K . Plasmodium liver stage developmental arrest by depletion of a protein at the parasite-host interface. Proc Natl Acad Sci U S A. 2005; 102(8):3022-7. PMC: 548321. DOI: 10.1073/pnas.0408442102. View

12.

Balaji S, Babu M, Iyer L, Aravind L . Discovery of the principal specific transcription factors of Apicomplexa and their implication for the evolution of the AP2-integrase DNA binding domains. Nucleic Acids Res. 2005; 33(13):3994-4006. PMC: 1178005. DOI: 10.1093/nar/gki709. View

13.

Tarun A, Peng X, Dumpit R, Ogata Y, Silva-Rivera H, Camargo N . A combined transcriptome and proteome survey of malaria parasite liver stages. Proc Natl Acad Sci U S A. 2008; 105(1):305-10. PMC: 2224207. DOI: 10.1073/pnas.0710780104. View

14.

Iyer L, Anantharaman V, Wolf M, Aravind L . Comparative genomics of transcription factors and chromatin proteins in parasitic protists and other eukaryotes. Int J Parasitol. 2007; 38(1):1-31. DOI: 10.1016/j.ijpara.2007.07.018. View

15.

Yuda M, Iwanaga S, Shigenobu S, Kato T, Kaneko I . Transcription factor AP2-Sp and its target genes in malarial sporozoites. Mol Microbiol. 2009; 75(4):854-63. DOI: 10.1111/j.1365-2958.2009.07005.x. View

16.

Schofield L, Villaquiran J, Ferreira A, Schellekens H, Nussenzweig R, NUSSENZWEIG V . Gamma interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites. Nature. 1987; 330(6149):664-6. DOI: 10.1038/330664a0. View

17.

Mueller A, Labaied M, Kappe S, Matuschewski K . Genetically modified Plasmodium parasites as a protective experimental malaria vaccine. Nature. 2004; 433(7022):164-7. DOI: 10.1038/nature03188. View

18.

Butler N, Schmidt N, Vaughan A, Aly A, Kappe S, Harty J . Superior antimalarial immunity after vaccination with late liver stage-arresting genetically attenuated parasites. Cell Host Microbe. 2011; 9(6):451-62. PMC: 3117254. DOI: 10.1016/j.chom.2011.05.008. View

19.

Janse C, Franke-Fayard B, Mair G, Ramesar J, Thiel C, Engelmann S . High efficiency transfection of Plasmodium berghei facilitates novel selection procedures. Mol Biochem Parasitol. 2005; 145(1):60-70. DOI: 10.1016/j.molbiopara.2005.09.007. View

20.

Silvie O, Goetz K, Matuschewski K . A sporozoite asparagine-rich protein controls initiation of Plasmodium liver stage development. PLoS Pathog. 2008; 4(6):e1000086. PMC: 2398788. DOI: 10.1371/journal.ppat.1000086. View